Novozymes
Encyclopedia
Novozymes is a biotech-based company, headquartered in Denmark
and employing approximately 5,400 people in 30 countries. Novozymes A/S’ B shares are listed on the NASDAQ OMX Nordic
.
ingredients accounting for respectively 94%, 4% and 2% of sale, respectively (2010) . Novozymes markets approximately 700 different products worldwide.
capital is held by Novo A/S, a wholly owned subsidiary of the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares, which overall gives Novo A/S 25.5% of the total share capital and 70.1% of the votes.
Novozymes A/S' B shares are listed on the NASDAQ OMX Nordic
and are traded under the abbreviated name NZYM B and the ID code/ISIN DK0010272129. The B shares are issued in units of DKK 10.
Each A share carries the right to cast one hundred votes at the company's shareholders' meeting, each B share the right to cast ten votes.
Denmark
Denmark is a Scandinavian country in Northern Europe. The countries of Denmark and Greenland, as well as the Faroe Islands, constitute the Kingdom of Denmark . It is the southernmost of the Nordic countries, southwest of Sweden and south of Norway, and bordered to the south by Germany. Denmark...
and employing approximately 5,400 people in 30 countries. Novozymes A/S’ B shares are listed on the NASDAQ OMX Nordic
Copenhagen Stock Exchange
The Copenhagen Stock Exchange or CSE is an international marketplace for Danish securities, including shares, bonds, treasury bills and notes, and financial futures and options...
.
Business areas
Novozymes' business in divided into three areas: Enzymes for industrial use, Microorganisms and BiopharmaceuticalBiopharmaceutical
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins , nucleic acids and living microorganisms like virus and bacteria where the virulence of viruses and bacteria is reduced by the process of attenuation, they can be used for therapeutic or in vivo diagnostic...
ingredients accounting for respectively 94%, 4% and 2% of sale, respectively (2010) . Novozymes markets approximately 700 different products worldwide.
Enzymes
Enzymes are divided into the following categories:- Household care. Enzymes used in laundry detergents and automatic dish washing machines.
- Technical enzymes. The most important products in this business area are enzymes for the starch, textile and bioethanol industries, as well as enzymes for the leather and forest products industries and various other smaller industries.
- Food enzymes. Food enzymes include products for the baking, brewing, beverage alcohol, fruit juice and wine industries, and other food industries such as the dairy industry and the oils & fats industry.
- Feed enzymes. Includes enzymes for the animal feed industries.
Biopharmaceuticals
Biopharmaceutical ingredients comprise of regulatory-compliant, protein based products and technologies dedicated to the biopharmaceutical industry, adding value through efficiency - from manufacture to final drug formulation and drug delivery.Microorganisms
The microorganisms business area includes microorganisms for:- Institutional and household cleaning
- Wastewater treatment
- Aquaculture
- Bioagriculture
Ownership
The Novozymes A shareA share
In finance the term A share has two distinct meanings, both relating to securities.* The first is a designation for a 'class' of common or preferred stock. A shares of common or preferred stock typically have enhanced voting rights or other benefits compared to the other forms of shares that may...
capital is held by Novo A/S, a wholly owned subsidiary of the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares, which overall gives Novo A/S 25.5% of the total share capital and 70.1% of the votes.
Novozymes A/S' B shares are listed on the NASDAQ OMX Nordic
Copenhagen Stock Exchange
The Copenhagen Stock Exchange or CSE is an international marketplace for Danish securities, including shares, bonds, treasury bills and notes, and financial futures and options...
and are traded under the abbreviated name NZYM B and the ID code/ISIN DK0010272129. The B shares are issued in units of DKK 10.
Each A share carries the right to cast one hundred votes at the company's shareholders' meeting, each B share the right to cast ten votes.
Timeline
- 1925 Novo Terapeutisk Laboratorium (hereafter called Novo) founded with the aim to produce insulin.
- 1941 Novo launches its first enzyme, trypsin, extracted from the pancreasPancreasThe pancreas is a gland organ in the digestive and endocrine system of vertebrates. It is both an endocrine gland producing several important hormones, including insulin, glucagon, and somatostatin, as well as a digestive organ, secreting pancreatic juice containing digestive enzymes that assist...
of animals and used to soften leather. - 1963 Alcalase – Novo’s first detergent enzyme produced by fermentationIndustrial fermentationIndustrial fermentation is the intentional use of fermentation by microorganisms such as bacteria and fungi to make products useful to humans. Fermented products have applications as food as well as in general industry.- Food fermentation :...
. - 1984 Launch of Maltogenase® for the starch industry. The world’s first enzyme for industrial use produced by genetically modified organisms.
- 1987 Launch of Lipolase®. The world's first fat-splitting enzyme for detergents manufactured with genetically engineered microorganisms.
- 2000 Novo splits into three separate companies operating under the umbrella of the Novo Group: Novo A/S, Novo Nordisk A/SNovo NordiskNovo Nordisk manufactures and markets pharmaceutical products and services. Created in 1989 through a merger of two Danish companies dating back to the 1920s, it has become one of the world's leading companies in diabetes care, where Novo Nordisk pursues research into pulmonary delivery systems;...
, and Novozymes A/S. Initial offering of Novozymes shares: DKK 150. Revenue (turnover) in year 2000: DKK 5,033 million. - 2001 Novozymes launches a new business strategy, expanded to include initiatives outside the core enzyme business.
- 2003 Novozymes buys five smaller companies to form microorganism business unit.
- 2007 Novozymes forms new biopharmaceutical ingredients business unit based on the acquisitions of three smaller companies.
- 2010 Novozymes acquires Turfal (Brazil) to strengthen position in bioagriculture market.
- 2010 Novozymes announces plans to acquire EMDEMD- Music :* E.M.D., a Swedish band* The Explorations in Music and Dance / EMD Network, represents diverse higher education institutions of dance and music in Greenland, Finland, Sweden, Denmark, Iceland, Norway, Estonia, Latvia, and Lithuania with additional institutional partners in the European...
/MerckMerckMerck may refer to:* Merck KGaA, , a German-based chemical and pharmaceutical company.** Merck Serono , the pharmaceutical division of Merck KGaA...
Crop BioScience Inc. making the largest major player in sustainable solutions for the agricultural biologicals industry.